The Union Health Ministry has amended India’s Drugs Rules to end the over-the-counter sale of cough syrups and other syrup-based medicines nationwide. The change removes “syrups” from the Schedule K exemption list under the Drugs and Cosmetics framework, so pharmacies can dispense these products only with a valid prescription from a registered medical practitioner. Multiple reports say the amendment is notified in the Official Gazette in early June 2026 and is implemented across the country, including in smaller towns and villages where relaxed dispensing rules had previously applied.
The move follows repeated safety and misuse concerns. Reporting links the regulatory tightening to child deaths in Madhya Pradesh and Rajasthan associated with contaminated cough syrups, renewing scrutiny of quality and oversight of liquid medicines. The earlier Schedule K provisions had allowed certain syrup preparations to be sold without prescription under specified exemptions.
The stated intent is to improve drug safety, reduce indiscriminate or unsupervised use, limit unauthorised sales, and strengthen accountability through standard regulatory oversight. Industry and pharmacy bodies in some reporting have welcomed the decision as closing loopholes and aligning distribution with prescription-based control.